Document:

<PAGE>

                                                                     EXHIBIT 4.7

                             SUPPLEMENTAL INDENTURE
                    TO BE DELIVERED BY SUBSEQUENT GUARANTORS

         SUPPLEMENTAL INDENTURE (this "Supplemental Indenture") dated as of
April 1, 2003, among Jordan Valley Hospital, LP (the "Guaranteeing Subsidiary"),
a subsidiary of IASIS Healthcare Corporation (or its successor), a corporation
organized under the laws of Delaware (the "Company"), and The Bank of New York,
as trustee under the indenture referred to below (the "Trustee").

                               W I T N E S S E T H

         WHEREAS, the Company has heretofore executed and delivered to the
Trustee an indenture (the "Indenture"), dated as of October 15, 1999, providing
for the issuance of an aggregate principal amount at maturity of $230,000,000 of
13% Senior Subordinated Notes due 2009 (the "Notes");

         WHEREAS, the Indenture provides that under certain circumstances the
Guaranteeing Subsidiary shall execute and deliver to the Trustee a supplemental
indenture pursuant to which the Guaranteeing Subsidiary shall unconditionally
guarantee all of the Company's Obligations under the Notes and the Indenture on
the terms and conditions set forth herein (the "Subsidiary Guarantee"); and

         WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is
authorized to execute and deliver this Supplemental Indenture.

         NOW THEREFORE, in consideration of the foregoing and for other good and
valuable consideration, the receipt of which is hereby acknowledged, the
Guaranteeing Subsidiary and the Trustee mutually covenant and agree for the
equal and ratable benefit of the Holders of the Notes as follows:

         1.       Capitalized Terms. Capitalized terms used herein without
definition shall have the meanings assigned to them in the Indenture.

         2.       Agreement to Guarantee. The Guaranteeing Subsidiary hereby
agrees as follows:

                  (a)      Along with all Guarantors named in the Indenture, to
                           jointly and severally Guarantee to each Holder of a
                           Note authenticated and delivered by the Trustee and
                           to the Trustee and its successors and assigns,
                           irrespective of the validity and enforceability of
                           the Indenture, the Notes or the obligations of the
                           Company hereunder or thereunder, that:

                                    (i)      the principal of and interest on
                                             the Notes will be promptly paid in
                                             full when due, whether at maturity,
                                             by acceleration, redemption or
                                             otherwise, and interest on the
                                             overdue principal of and interest
                                             on the Notes, if any, if lawful,
                                             and all other obligations of the
                                             Company to the Holders or the

<PAGE>

                                             Trustee hereunder or thereunder
                                             will be promptly paid in full or
                                             performed, all in accordance with
                                             the terms hereof and thereof; and

                                    (ii)     in case of any extension of time of
                                             payment or renewal of any Notes or
                                             any of such other obligations, that
                                             same will be promptly paid in full
                                             when due or performed in accordance
                                             with the terms of the extension or
                                             renewal, whether at stated
                                             maturity, by acceleration or
                                             otherwise. Failing payment when due
                                             of any amount so guaranteed or any
                                             performance so guaranteed for
                                             whatever reason, the Guarantors
                                             shall be jointly and severally
                                             obligated to pay the same
                                             immediately.

                  (b)      The obligations hereunder shall be unconditional,
                           irrespective of the validity, regularity or
                           enforceability of the Notes or the Indenture, the
                           absence of any action to enforce the same, any waiver
                           or consent by any Holder of the Notes with respect to
                           any provisions hereof or thereof, the recovery of any
                           judgment against the Company, any action to enforce
                           the same or any other circumstance which might
                           otherwise constitute a legal or equitable discharge
                           or defense of a guarantor.

                  (c)      The following is hereby waived: diligence
                           presentment, demand of payment, filing of claims with
                           a court in the event of insolvency or bankruptcy of
                           the Company, any right to require a proceeding first
                           against the Company, protest, notice and all demands
                           whatsoever.

                  (d)      This Subsidiary Guarantee shall not be discharged
                           except by complete performance of the obligations
                           contained in the Notes and the Indenture.

                  (e)      If any Holder or the Trustee is required by any court
                           or otherwise to return to the Company, the
                           Guarantors, or any Custodian, Trustee, liquidator or
                           other similar official acting in relation to either
                           the Company or the Guarantors, any amount paid by
                           either to the Trustee or such Holder, this Subsidiary
                           Guarantee, to the extent theretofore discharged,
                           shall be reinstated in full force and effect.

                  (f)      The Guaranteeing Subsidiary shall not be entitled to
                           any right of subrogation in relation to the Holders
                           in respect of any obligations guaranteed hereby until
                           payment in full of all obligations guaranteed hereby.

                  (g)      As between the Guarantors, on the one hand, and the
                           Holders and the Trustee, on the other hand, (x) the
                           maturity of the obligations guaranteed hereby may be
                           accelerated as provided in Article 6 of the Indenture
                           for the purposes of this Subsidiary Guarantee,
                           notwithstanding any stay,

<PAGE>

                           injunction or other prohibition preventing such
                           acceleration in respect of the obligations guaranteed
                           hereby, and (y) in the event of any declaration of
                           acceleration of such obligations as provided in
                           Article 6 of the Indenture, such obligations (whether
                           or not due and payable) shall forthwith become due
                           and payable by the Guarantors for the purpose of this
                           Subsidiary Guarantee.

                  (h)      The Guarantors shall have the right to seek
                           contribution from any non-paying Guarantor so long as
                           the exercise of such right does not impair the rights
                           of the Holders under the Guarantee.

                  (i)      The obligations hereunder shall be subject to the
                           subordination provisions of the Indenture.

         3.       Execution and Delivery. Each Guaranteeing Subsidiary agrees
that the Subsidiary Guarantees shall remain in full force and effect
notwithstanding any failure to endorse on each Note a notation of such
Subsidiary Guarantee.

         4.       Guaranteeing Subsidiary May Consolidate, Etc. on Certain
Terms.

                  (a)      The Guaranteeing Subsidiary may not consolidate with
                           or merge with or into (whether or not such Guarantor
                           is the surviving Person) another corporation, Person
                           or entity whether or not affiliated with such
                           Guarantor unless:

                                    (i)      subject to Section 11.05 of the
                                    Indenture, the Person formed by or surviving
                                    any such consolidation or merger (if other
                                    than a Guarantor or the Company)
                                    unconditionally assumes all the obligations
                                    of such Guarantor, pursuant to a
                                    supplemental indenture in form and substance
                                    reasonably satisfactory to the Trustee,
                                    under the Notes, the Indenture and the
                                    Subsidiary Guarantee on the terms set forth
                                    herein or therein; and

                                    (ii)     immediately after giving effect to
                                    such transaction, no Default or Event of
                                    Default exists.

                  (b)      In case of any such consolidation, merger, sale or
                           conveyance and upon the assumption by the successor
                           corporation, by supplemental indenture, executed and
                           delivered to the Trustee and satisfactory in form to
                           the Trustee, of the Subsidiary Guarantee endorsed
                           upon the Notes and the due and punctual performance
                           of all of the covenants and conditions of the
                           Indenture to be performed by the Guarantor, such
                           successor corporation shall succeed to and be
                           substituted for the Guarantor with the same effect as
                           if it had been named herein as a Guarantor. Such
                           successor corporation thereupon may cause to be
                           signed any or all of the Subsidiary Guarantees to be
                           endorsed upon all of the Notes issuable hereunder
                           which theretofore shall not have been signed by the

                                       3

<PAGE>

                           Company and delivered to the Trustee. All the
                           Subsidiary Guarantees so issued shall in all respects
                           have the same legal rank and benefit under the
                           Indenture as the Subsidiary Guarantees theretofore
                           and thereafter issued in accordance with the terms of
                           the Indenture as though all of such Subsidiary
                           Guarantees had been issued at the date of the
                           execution hereof.

                  (c)      Except as set forth in Articles 4 and 5 of the
                           Indenture, and notwithstanding clauses (a) and (b)
                           above, nothing contained in the Indenture or in any
                           of the Notes shall prevent any consolidation or
                           merger of a Guarantor with or into the Company or
                           another Guarantor, or shall prevent any sale or
                           conveyance of the property of a Guarantor as an
                           entirety or substantially as an entirety to the
                           Company or another Guarantor.

         5.       Releases.

                  (a)      In the event of a sale or other disposition of all of
                           the assets of any Guarantor, by way of merger,
                           consolidation or otherwise, or a sale or other
                           disposition of all to the capital stock of any
                           Guarantor, then such Guarantor (in the event of a
                           sale or other disposition, by way of merger,
                           consolidation or otherwise, of all of the capital
                           stock of such Guarantor) or the corporation acquiring
                           the property (in the event of a sale or other
                           disposition of all or substantially all of the assets
                           of such Guarantor) will be released and relieved of
                           any obligations under its Subsidiary Guarantee;
                           provided that the Net Proceeds of such sale or other
                           disposition are applied in accordance with the
                           applicable provisions of the Indenture, including
                           without limitation Section 4.10 of the Indenture.
                           Upon delivery by the Company to the Trustee of an
                           Officers' Certificate and an Opinion of Counsel to
                           the effect that such sale or other disposition was
                           made by the Company in accordance with the provisions
                           of the Indenture, including without limitation
                           Section 4.10 of the Indenture, the Trustee shall
                           execute any documents reasonably required in order to
                           evidence the release of any Guarantor from its
                           obligations under its Subsidiary Guarantee.

                  (b)      Any Guarantor not released from its obligations under
                           its Subsidiary Guarantee shall remain liable for the
                           full amount of principal of and interest on the Notes
                           and for the other obligations of any Guarantor under
                           the Indenture as provided in Article 11 of the
                           Indenture.

         6.       No Recourse Against Others. No past, present or future
director, officer, employee, incorporator, stockholder or agent of the
Guaranteeing Subsidiary, as such, shall have any liability for any obligations
of the Company or any Guaranteeing Subsidiary under the Notes, any Subsidiary
Guarantees, the Indenture or this Supplemental Indenture or for any claim based
on, in respect of, or by reason of, such obligations or their creation. Each
Holder of the Notes by accepting a Note waives and releases all such liability.
The waiver and release are part of the consideration for issuance of the Notes.
Such waiver may not be effective to waive

                                       4

<PAGE>

liabilities under the federal securities laws and it is the view of the SEC that
such a waiver is against public policy.

         7.       NEW YORK LAW TO GOVERN. THE INTERNAL LAW OF THE STATE OF NEW
YORK SHALL GOVERN AND BE USED TO CONSTRUE THIS SUPPLEMENTAL INDENTURE BUT
WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT
THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED
THEREBY.

         8.       Counterparts. The parties may sign any number of copies of
this Supplemental Indenture. Each signed copy shall be an original, but all of
them together represent the same agreement.

         9.       Effect of Headings. The Section headings herein are for
convenience only and shall not affect the construction hereof.

         10.      The Trustee. The Trustee shall not be responsible in any
manner whatsoever for or in respect of the validity or sufficiency of this
Supplemental Indenture or for or in respect of the recitals contained herein,
all of which recitals are made solely by the Guaranteeing Subsidiary and the
Company.

         IN WITNESS WHEREOF, the parties hereto have caused this Supplemental
Indenture to be duly executed and attested, all as of the date first above
written.

         Dated: April 1, 2003

                                           JORDAN VALLEY HOSPITAL, LP

                                           By: IASIS HEALTHCARE HOLDINGS, INC.,
                                                   as General Partner

                                           By: /s/ Frank A. Coyle
                                               -----------------------------
                                           Name:  Frank A. Coyle
                                           Title: Secretary

                                           THE BANK OF NEW YORK,
                                                    as Trustee

                                           By:  /s/ Robert A. Massimillo
                                                ----------------------------
                                           Name:  Robert A. Massimillo
                                           Title: Vice President

                                       5<PAGE>
                                                                    EXHIBIT 4.11

                                                                  EXECUTION COPY

================================================================================

                          REGISTRATION RIGHTS AGREEMENT

                            Dated as of June 6, 2003

                                  by and among

                          IASIS HEALTHCARE CORPORATION,

                        The Guarantors Signatories Hereto

                                       and

                         BANC OF AMERICA SECURITIES LLC
                            BEAR, STEARNS & CO. INC.
                          CITIGROUP GLOBAL MARKETS INC.

================================================================================

<PAGE>

         This Registration Rights Agreement (this "Agreement") is made and
entered into as of June 6, 2003, by and among IASIS Healthcare Corporation, a
Delaware corporation (the "Company"), the subsidiaries of the Company listed on
the signature pages hereof (the "Guarantors") and Banc of America Securities
LLC, Bear, Stearns & Co. Inc. and Citigroup Global Markets Inc. (collectively,
the "Initial Purchasers"), who have agreed to purchase the Company's 81/2%
Senior Subordinated Notes due 2009 (the "Series A Notes") pursuant to the
Purchase Agreement (as defined below).

         This Agreement is made pursuant to the Purchase Agreement, dated May
22, 2003 (the "Purchase Agreement"), by and among the Company, the Guarantors
and the Initial Purchasers. In order to induce the Initial Purchasers to
purchase the Series A Notes, the Company and the Guarantors have agreed to
provide the registration rights set forth in this Agreement. The execution and
delivery of this Agreement is a condition to the obligations of the Initial
Purchasers set forth in Section 6 of the Purchase Agreement. Capitalized terms
used herein and not otherwise defined shall have the meaning assigned to them in
the Indenture, dated as of the date hereof, by and among the Company, the
Guarantors and The Bank of New York, as Trustee (the "Trustee"), relating to the
Series A Notes and the Series B Notes (as defined below) (the "Indenture").

         The parties hereby agree as follows:

SECTION 1. DEFINITIONS

         As used in this Agreement, the following capitalized terms shall have
the following meanings:

         Act: The Securities Act of 1933, as amended.

         Affiliate: As defined in Rule 144 of the Act.

         Broker-Dealer: Any broker or dealer registered under the Exchange Act.

         Business Day: Any day except a Saturday, Sunday or other day in the
City of New York on which banks are authorized or ordered to close.

         Closing Date: The date hereof.

         Commission: The Securities and Exchange Commission.

         Consummate: An Exchange Offer shall be deemed "Consummated" for
purposes of this Agreement upon the occurrence of (a) the filing and
effectiveness under the Act of the Exchange Offer Registration Statement
relating to the Series B Notes to be issued in the Exchange Offer, (b) the
maintenance of such Exchange Offer Registration Statement continuously effective
and the keeping of such Exchange Offer open for a period not less than the
minimum period required pursuant to Section 3(b) hereof and (c) the delivery by
the Company to the Registrar under the Indenture of Series B Notes to be
registered in the same aggregate principal amount as the aggregate principal
amount of Series A Notes tendered by the Holders thereof pursuant to the
Exchange Offer.

         Effectiveness Deadline: As defined in Section 3(a) and 4(a) hereof.

<PAGE>

         Exchange Act: The Securities Exchange Act of 1934, as amended and the
rules and regulations of the Commission promulgated thereunder.

         Exchange Offer: The exchange and issuance by the Company of a principal
amount of Series B Notes (which shall be registered pursuant to the Exchange
Offer Registration Statement) equal to the outstanding principal amount of
Series A Notes that are tendered by such Holders in connection with such
exchange and issuance.

         Exchange Offer Registration Statement: The Registration Statement
relating to the Exchange Offer, including the related Prospectus.

         Filing Deadline: As defined in Sections 3(a) and 4(a) hereof.

         Guarantors: The Guarantors defined in the preamble hereto and any
Person which becomes a guarantor of Notes after the date hereof pursuant to the
terms of the Indenture.

         Holders: As defined in Section 2 hereof.

         Indemnified Holder: As defined in Section 8(a) hereof.

         Indemnified Party: As defined in Section 8(c) hereof.

         Indemnifying Party: As defined in Section 8(c) hereof.

         Liquidated Damages: As defined in Section 5 hereof.

         Notes: Series A Notes and Series B Notes (including guarantees thereof
by the Guarantors).

         Person: An individual, partnership, limited liability company,
corporation, trust, unincorporated organization, or a government or agency or
political subdivision thereof.

         Prospectus: The prospectus included in a Registration Statement at the
time such Registration Statement is declared effective, as amended or
supplemented by any prospectus supplement and by all other amendments thereto,
including post-effective amendments, and all material incorporated by reference
into such Prospectus.

         Recommencement Date: As defined in Section 6(d) hereof.

         Registration Default: As defined in Section 5 hereof.

         Registration Statement: Any registration statement of the Company and
the Guarantors relating to (a) an offering of any Series B Notes (including
guarantees thereof by the Guarantors) pursuant to an Exchange Offer or (b) the
registration for resale of Transfer Restricted Securities pursuant to the Shelf
Registration Statement, in each case, (i) that is filed pursuant to the
provisions of this Agreement and (ii) including the Prospectus included therein,
all amendments and supplements thereto (including post-effective amendments) and
all exhibits and material incorporated by reference therein.

         Regulation S: Regulation S promulgated under the Act.

                                       2

<PAGE>

         Rule 144: Rule 144 promulgated under the Act.

         Series B Notes: The Company's 8 1/2% Senior Notes due 2009 to be issued
pursuant to the Indenture: (i) in the Exchange Offer or (ii) as contemplated by
Section 4 hereof.

         Shelf Registration Statement: As defined in Section 4 hereof.

         Suspension Notice: As defined in Section 6(d) hereof.

         TIA: The Trust Indenture Act of 1939 (15 U.S.C. Section 77aaa-77bbbb)
as in effect on the date of the Indenture.

         Transfer Restricted Securities: Each Series A Note, until the earliest
to occur of (a) the date on which such Series A Note is exchanged in an Exchange
Offer for a Series B Note and entitled to be resold to the public by the Holder
thereof without complying with the prospectus delivery requirements of the Act,
(b) the date on which such Series A Note has been disposed of in accordance with
a Shelf Registration Statement (and the purchasers thereof have been issued
Series B Notes), and (c) the date on which such Series B Note is disposed of by
a Broker-Dealer pursuant to the "Plan of Distribution" contemplated by an
Exchange Offer Registration Statement (including the delivery of the Prospectus
contained therein) or (d) the date which such Series A Note is distributed to
the public pursuant to Rule 144 under the Act (and the purchasers thereof have
been issued Series B Notes).

SECTION 2. HOLDERS

         A Person is deemed to be a holder of Transfer Restricted Securities
(each, a "Holder") whenever such Person owns Transfer Restricted Securities.

SECTION 3. REGISTERED EXCHANGE OFFER

         (a)      Unless the Exchange Offer shall not be permitted by applicable
federal law or policy of the Commission (after the procedures set forth in
Section 6(a)(i) below have been complied with), the Company and the Guarantors
shall (i) cause the Exchange Offer Registration Statement to be filed with the
Commission as soon as practicable after the Closing Date, but in no event later
than 90 days after the Closing Date (such 90th day being the "Filing Deadline"),
(ii) use their commercially reasonable efforts to cause such Exchange Offer
Registration Statement to become effective at the earliest possible time, but in
no event later than 180 days after the Closing Date (such 180th day being the
"Effectiveness Deadline"), (iii) in connection with the foregoing, (A) file all
pre-effective amendments to such Exchange Offer Registration Statement as may be
necessary in order to cause it to become effective, (B) file, if applicable, a
post-effective amendment to such Exchange Offer Registration Statement pursuant
to Rule 430A under the Act and (C) cause all necessary filings, if any, in
connection with the registration and qualification of the Series B Notes to be
made under the Blue Sky laws of such jurisdictions as are necessary to permit
Consummation of the Exchange Offer, and (iv) upon the effectiveness of such
Exchange Offer Registration Statement, use their commercially reasonable efforts
to commence and Consummate the Exchange Offer. The Exchange Offer shall be on
the appropriate form permitting registration of the Series B Notes to be offered
in exchange for Series A Notes that are Transfer Restricted Securities and to
permit resales of Series B Notes by any Broker-Dealer that tendered into the
Exchange Offer for Series A Notes that such Broker-Dealer acquired for its own
account

                                       3

<PAGE>

as a result of market making activities or other trading activities (other than
Series A Notes acquired directly from the Company or any of its Affiliates) as
contemplated by Section 3(c) below.

         (b)      The Company and the Guarantors shall use their commercially
reasonable efforts to cause the Exchange Offer Registration Statement to be
effective continuously, and shall keep the Exchange Offer open for a period of
not less than the minimum period required under applicable federal and state
securities laws to Consummate the Exchange Offer; provided, however, that in no
event shall such period be less than 20 Business Days. The Company and the
Guarantors shall cause the Exchange Offer to comply with all applicable federal
and state securities laws. No securities other than the Series B Notes and the
guarantees thereof shall be included in the Exchange Offer Registration
Statement. The Company and the Guarantors shall use their commercially
reasonable efforts to cause the Exchange Offer to be Consummated on or prior to
the date that is 30 Business Days after the Exchange Offer Registration
Statement has become effective, or longer, if required by the federal securities
laws.

         (c)      The Company and the Guarantors shall include a "Plan of
Distribution" section in the Prospectus contained in the Exchange Offer
Registration Statement and indicate therein that any Broker-Dealer who holds
Transfer Restricted Securities that were acquired for the account of such
Broker-Dealer as a result of market-making activities or other trading
activities (other than Series A Notes acquired directly from the Company or any
Affiliate of the Company), may exchange such Transfer Restricted Securities
pursuant to the Exchange Offer; however, such Broker-Dealer may be deemed to be
an "underwriter" within the meaning of the Act and must, therefore, deliver a
prospectus meeting the requirements of the Act in connection with its initial
sale of any Exchange Notes received by such Broker-Dealer in the Exchange Offer
and that the Prospectus contained in the Exchange Offer Registration Statement
may be used to satisfy such prospectus delivery requirement. Such "Plan of
Distribution" section shall also contain all other information with respect to
such sales by such Broker-Dealers that the Commission may require in order to
permit such sales pursuant thereto, but such "Plan of Distribution" shall not
name any such Broker-Dealer or disclose the amount of Transfer Restricted
Securities held by any such Broker-Dealer, except to the extent required by the
Commission as a result of a change in policy, rules or regulations after the
date of this Agreement.

         To the extent necessary to ensure that the Exchange Offer Registration
Statement is available for sales of Series B Notes by Broker-Dealers, the
Company and the Guarantors agree to use their commercially reasonable efforts to
keep the Exchange Offer Registration Statement continuously effective,
supplemented and amended as required by the provisions of Sections 6(a) and (c)
hereof and in conformity with the requirements of this Agreement, the Act and
the policies, rules and regulations of the Commission as announced from time to
time, for a period of 180 days from the date on which the Exchange Offer is
Consummated, or such shorter period as will terminate when all Transfer
Restricted Securities covered by such Registration Statement have been sold
pursuant thereto. The Company and the Guarantors shall promptly provide
sufficient copies of the latest version of such Prospectus to such
Broker-Dealers promptly upon request, and in no event later than one day after
such request, at any time during such period.

                                       4

<PAGE>

SECTION 4. SHELF REGISTRATION

         (a)      Shelf Registration. If (i) the Exchange Offer is not permitted
by applicable law or policy of the Commission (after the Company and the
Guarantors have complied with the procedures set forth in Section 6(a)(i) below)
or (ii) any Holder of Transfer Restricted Securities shall notify the Company in
writing prior to the 20th Business Day following the Consummation of the
Exchange Offer that (A) upon advice of counsel such Holder was prohibited by law
or Commission policy from participating in the Exchange Offer or (B) such Holder
may not resell the Series B Notes acquired by it in the Exchange Offer to the
public without delivering a prospectus and the Prospectus contained in the
Exchange Offer Registration Statement is not appropriate or available for such
resales by such Holder or (C) such Holder is a Broker-Dealer and holds Series A
Notes acquired directly from the Company or any of its Affiliates, then the
Company and the Guarantors shall:

     (x)  use their commercially reasonable efforts to cause to be filed, on or
prior to 30 days after the earlier of (i) the date on which the Company
determines that the Exchange Offer Registration Statement cannot be filed as a
result of clause (a)(i) above and (ii) the date on which the Company receives
the notice specified in clause (a)(ii) above, (such earlier date, the "Filing
Deadline"), a shelf registration statement pursuant to Rule 415 under the Act
(which may be an amendment to the Exchange Offer Registration Statement (the
"Shelf Registration Statement")), relating to all Transfer Restricted Securities
of Holders which shall have provided the information required pursuant to
Section 4(b) hereof, and

     (y)  use their commercially reasonable efforts to cause such Shelf
Registration Statement to become effective on or prior to 90 days after the
Filing Deadline (such 90th day the "Effectiveness Deadline").

         If, after the Company and the Guarantors have filed an Exchange Offer
Registration Statement that satisfies the requirements of Section 3(a) above,
the Company is required to file and make effective a Shelf Registration
Statement solely because the Exchange Offer is not permitted under applicable
federal law or policy of the Commission (i.e., clause (a)(i) above), then the
filing of the Exchange Offer Registration Statement shall be deemed to satisfy
the requirements of clause (x) above; provided that, in such event, the Company
and the Guarantors shall remain obligated to meet the Effectiveness Deadline set
forth in clause (y).

         The Company and the Guarantors shall use their commercially reasonable
efforts to keep any Shelf Registration Statement required by this Section 4(a)
continuously effective, supplemented and amended as required by and subject to
the provisions of Sections 6(b) and (c) hereof to the extent necessary to ensure
that it is available for sales of Transfer Restricted Securities by the Holders
thereof entitled to the benefit of this Section 4(a) and to ensure that it
conforms with the requirements of this Agreement, the Act and the policies,
rules and regulations of the Commission as announced from time to time, for a
period of at least two years (as extended pursuant to Sections 6(c)(i) and (d))
following the Closing Date, or such shorter period as will terminate when all
Transfer Restricted Securities covered by such Shelf Registration Statement have
been sold pursuant thereto.

         (b)      Provision by Holders of Certain Information in Connection with
the Shelf Registration Statement. No Holder of Transfer Restricted Securities
may include any of its Transfer Restricted Securities in any Shelf Registration
Statement pursuant to this Agreement

                                       5

<PAGE>

unless and until such Holder furnishes to the Company in writing, within 20 days
after receipt of a request therefor, the information specified in Item 507 or
508 of Regulation S-K, as applicable, of the Act for use in connection with any
Shelf Registration Statement or Prospectus or preliminary Prospectus included
therein. No Holder of Transfer Restricted Securities shall be entitled to
Liquidated Damages pursuant to Section 5 hereof unless and until such Holder
shall have provided all such information (it being understood that Liquidated
Damages shall not accrue for the benefit of any Holder until such Holder
provides such information). Each selling Holder agrees to promptly furnish to
the Company additional information required to be disclosed in order to make the
information previously furnished to the Company by such Holder not materially
misleading.

SECTION 5. LIQUIDATED DAMAGES

         If (i) any Registration Statement required by this Agreement is not
filed with the Commission on or prior to the applicable Filing Deadline, (ii)
any such Registration Statement has not been declared effective by the
Commission on or prior to the applicable Effectiveness Deadline, (iii) the
Exchange Offer has not been Consummated within 30 Business Days after the
Exchange Offer Registration Statement is first declared effective by the
Commission or (iv) subject to Section 6(c)(i) any Registration Statement
required by this Agreement is filed and declared effective but thereafter ceases
to be effective or fails to be usable for its intended purpose without being
succeeded immediately by a post-effective amendment to such Registration
Statement that cures such failure and that is itself declared effective
immediately (each such event referred to in clauses (i) through (iv), a
"Registration Default"), then, subject to Section 4(b), the Company and the
Guarantors hereby jointly and severally agree to pay to each Holder of Transfer
Restricted Securities affected thereby liquidated damages ("Liquidated
Damages"), with respect to the first 90-day period immediately following the
occurrence of the first Registration Default, in an amount equal to a per annum
rate of 0.25% on the principal amount of Transfer Restricted Securities held by
such Holder. The amount of Liquidated Damages described in the preceding
sentence shall increase by an additional per annum rate of 0.25% with respect to
each subsequent 90-day period until all Registration Defaults have been cured,
up to a maximum amount of Liquidated Damages for all Registration Defaults of
1.00% per annum on the principal amount of Notes constituting Transfer
Restricted Securities; provided that the Company and the Guarantors shall in no
event be required to pay Liquidated Damages for more than one Registration
Default at any given time. Notwithstanding anything to the contrary set forth
herein, (1) upon filing of the Exchange Offer Registration Statement (and/or, if
applicable, the Shelf Registration Statement), in the case of (i) above, (2)
upon the effectiveness of the Exchange Offer Registration Statement (and/or, if
applicable, the Shelf Registration Statement), in the case of (ii) above, (3)
upon Consummation of the Exchange Offer, in the case of (iii) above, or (4) upon
the filing of a post-effective amendment to the Registration Statement or an
additional Registration Statement that causes the Exchange Offer Registration
Statement (and/or, if applicable, the Shelf Registration Statement) to again be
declared effective or made usable in the case of (iv) above, the Liquidated
Damages payable with respect to the Transfer Restricted Securities as a result
of such clause (i), (ii), (iii) or (iv), as applicable, shall cease.

         All accrued Liquidated Damages shall be paid to the Holders entitled
thereto, in the manner provided for the payment of interest in the Indenture, on
each Interest Payment Date, as more fully set forth in the Indenture and the
Notes. All obligations of the Company and the Guarantors set forth in the
preceding paragraph that are outstanding with respect to any Transfer Restricted

                                       6

<PAGE>

Security at the time such security ceases to be a Transfer Restricted Security
shall survive until such time as all such obligations with respect to such
security shall have been satisfied in full.

SECTION 6. REGISTRATION PROCEDURES

         (a)      Exchange Offer Registration Statement. In connection with the
Exchange Offer, the Company and the Guarantors shall (x) comply with all
applicable provisions of Section 6(c) below, (y) use their commercially
reasonable efforts to effect such exchange and to permit the resale of Series B
Notes by any Broker-Dealer that tendered in the Exchange Offer Series A Notes
that such Broker-Dealer acquired for its own account as a result of its market
making activities or other trading activities (other than Series A Notes
acquired directly from the Company or any of its Affiliates) being sold in
accordance with the intended method or methods of distribution thereof, and (z)
comply with all of the following provisions:

                  (i)      If, following the date hereof there has been
         announced a change in Commission policy with respect to exchange offers
         such as the Exchange Offer, that in the reasonable opinion of counsel
         to the Company raises a substantial question as to whether the Exchange
         Offer is permitted by applicable federal law, the Company and the
         Guarantors hereby agree to seek a no-action letter or other favorable
         decision from the Commission allowing the Company and the Guarantors to
         Consummate an Exchange Offer for such Transfer Restricted Securities.
         The Company and the Guarantors hereby agree to pursue the issuance of
         such a decision to the Commission staff level. In connection with the
         foregoing, the Company and the Guarantors hereby agree to take all such
         other actions as may be requested by the Commission or otherwise
         required in connection with the issuance of such decision, including
         without limitation (A) participating in telephonic conferences with the
         Commission, (B) delivering to the Commission staff an analysis prepared
         by counsel to the Company setting forth the legal bases, if any, upon
         which such counsel has concluded that such an Exchange Offer should be
         permitted and (C) diligently pursuing a resolution (which need not be
         favorable) by the Commission staff.

                  (ii)     As a condition to its participation in the Exchange
         Offer, each Holder of Transfer Restricted Securities (including,
         without limitation, any Holder who is a Broker-Dealer) shall furnish,
         upon the request of the Company, prior to the Consummation of the
         Exchange Offer, a written representation to the Company and the
         Guarantors (which may be contained in the letter of transmittal
         contemplated by the Exchange Offer Registration Statement) to the
         effect that (A) it is not an Affiliate of the Company, (B) it is not
         engaged in, and does not intend to engage in, and has no arrangement or
         understanding with any person to participate in, a distribution of the
         Series B Notes to be issued in the Exchange Offer and (C) it is
         acquiring the Series B Notes in its ordinary course of business. Each
         Holder using the Exchange Offer to participate in a distribution of the
         Series B Notes hereby acknowledges and agrees that, if the resales are
         of Series B Notes obtained by such Holder in exchange for Series A
         Notes acquired directly from the Company or an Affiliate thereof, it
         (1) could not, under Commission policy as in effect on the date of this
         Agreement, rely on the position of the Commission enunciated in Morgan
         Stanley and Co., Inc. (available June 5, 1991) and Exxon Capital
         Holdings Corporation (available May 13, 1988), as interpreted in the
         Commission's letter to Shearman & Sterling dated July 2, 1993, and
         similar no-action letters (including, if applicable, any no-action
         letter obtained pursuant to clause (i) above), and (2) must comply with
         the registration and prospectus delivery

                                       7

<PAGE>

         requirements of the Act in connection with a secondary resale
         transaction and that such a secondary resale transaction must be
         covered by an effective registration statement containing the selling
         security holder information required by Item 507 or 508, as applicable,
         of Regulation S-K.

                  (iii)    Prior to effectiveness of the Exchange Offer
         Registration Statement, the Company and the Guarantors shall provide a
         supplemental letter to the Commission (A) stating that the Company and
         the Guarantors are registering the Exchange Offer in reliance on the
         position of the Commission enunciated in Exxon Capital Holdings
         Corporation (available May 13, 1988), Morgan Stanley and Co., Inc.
         (available June 5, 1991) as interpreted in the Commission's letter to
         Shearman & Sterling dated July 2, 1993, and, if applicable, any
         no-action letter obtained pursuant to clause (i) above, (B) including a
         representation that neither the Company nor any Guarantor has entered
         into any arrangement or understanding with any Person to distribute the
         Series B Notes to be received in the Exchange Offer and that, to the
         best of the Company's and each Guarantor's information and belief, each
         Holder participating in the Exchange Offer is acquiring the Series B
         Notes in its ordinary course of business and has no arrangement or
         understanding with any Person to participate in the distribution of the
         Series B Notes received in the Exchange Offer and (C) any other
         undertaking or representation required by the Commission as set forth
         in any no-action letter obtained pursuant to clause (i) above, if
         applicable.

         (b)      Shelf Registration Statement. In connection with the Shelf
Registration Statement, the Company and the Guarantors shall comply with all the
provisions of Section 6(c) below and shall use their commercially reasonable
efforts to effect such registration to permit the sale of the Transfer
Restricted Securities being sold in accordance with the intended method or
methods of distribution thereof (as indicated in the information furnished to
the Company pursuant to Section 4(b) hereof), and pursuant thereto the Company
and the Guarantors will prepare and file with the Commission a Registration
Statement relating to the registration on any appropriate form under the Act,
which form shall be available for the sale of the Transfer Restricted Securities
in accordance with the intended method or methods of distribution thereof within
the time periods and otherwise in accordance with the provisions hereof.

         (c)      General Provisions. In connection with any Registration
Statement and any related Prospectus required by this Agreement, the Company and
the Guarantors shall:

                  (i)      use their commercially reasonable efforts to keep
         such Registration Statement continuously effective and provide all
         requisite financial statements for the period specified in Section 3 or
         4 of this Agreement, as applicable. Upon the occurrence of any event
         that would cause any such Registration Statement or the Prospectus
         contained therein (A) to contain an untrue statement of a material fact
         or omits to state any material fact necessary to make the statements
         therein not misleading or (B) not to be effective and usable for resale
         of Transfer Restricted Securities during the period required by this
         Agreement, the Company and the Guarantors shall file promptly an
         appropriate amendment to such Registration Statement curing such
         defect, and, if Commission review is required, use their commercially
         reasonable efforts to cause such amendment to be declared effective as
         soon as practicable. Notwithstanding the foregoing, if the Board of
         Directors of the Company determines in good faith that it is in the
         best interests of the Company and the

                                       8

<PAGE>

         Guarantors not to disclose the existence of or facts surrounding any
         proposed or pending material corporate transaction or other material
         development involving the Company or the Guarantors, the Company and
         the Guarantors may allow the Shelf Registration Statement to fail to be
         effective or the Prospectus contained therein to be unusable as a
         result of such nondisclosure for up to ninety (90) days in any year
         during the two-year period of effectiveness required by Section 4
         hereof;

                  (ii)     prepare and file with the Commission such amendments
         and post-effective amendments to the applicable Registration Statement
         as may be necessary to keep such Registration Statement effective for
         the applicable period set forth in Section 3 or 4 hereof, as the case
         may be; cause the Prospectus to be supplemented by any required
         Prospectus supplement, and as so supplemented to be filed pursuant to
         Rule 424 under the Act, and to comply fully with Rules 424, 430A and
         462, as applicable, under the Act in a timely manner; and comply with
         the provisions of the Act with respect to the disposition of all
         securities covered by such Registration Statement during the applicable
         period in accordance with the intended method or methods of
         distribution by the sellers thereof set forth in such Registration
         Statement or supplement to the Prospectus;

                  (iii)    with respect to a Shelf Registration Statement,
         advise the selling Holders promptly and, if requested by such Person,
         confirm such advice in writing, (A) when the Prospectus or any
         Prospectus supplement or post-effective amendment has been filed, and,
         with respect to any applicable Registration Statement or any
         post-effective amendment thereto, when the same has become effective,
         (B) of any request by the Commission for amendments to the Registration
         Statement or amendments or supplements to the Prospectus or for
         additional information relating thereto, (C) of the issuance by the
         Commission of any stop order suspending the effectiveness of the
         Registration Statement under the Act or of the suspension by any state
         securities commission of the qualification of the Transfer Restricted
         Securities for offering or sale in any jurisdiction, or the initiation
         of any proceeding for any of the preceding purposes, (D) of the
         existence of any fact or the happening of any event that makes any
         statement of a material fact made in the Registration Statement, the
         Prospectus, any amendment or supplement thereto or any document
         incorporated by reference therein untrue, or that requires the making
         of any additions to or changes in the Registration Statement in order
         to make the statements therein not misleading, or that requires the
         making of any additions to or changes in the Prospectus in order to
         make the statements therein, in the light of the circumstances under
         which they were made, not misleading. If at any time the Commission
         shall issue any stop order suspending the effectiveness of the
         Registration Statement, or any state securities commission or other
         regulatory authority shall issue an order suspending the qualification
         or exemption from qualification of the Transfer Restricted Securities
         under state securities or Blue Sky laws, the Company and the Guarantors
         shall use their commercially reasonable efforts to obtain the
         withdrawal or lifting of such order at the earliest possible time;

                  (iv)     subject to Section 6(c)(i), if any fact or event
         contemplated by Section 6(c)(iii)(D) above shall exist or have
         occurred, prepare a supplement or post-effective amendment to the
         Registration Statement or related Prospectus or any document
         incorporated therein by reference or file any other required document
         so that, as thereafter delivered to the purchasers of Transfer
         Restricted Securities, the Prospectus will not contain an untrue
         statement of a material fact or omit to state any material fact
         necessary to

                                       9

<PAGE>

         make the statements therein, in the light of the circumstances under
         which they were made, not misleading;

                  (v)      with respect to a Shelf Registration Statement,
         furnish to the Initial Purchasers and each selling Holder named in any
         Registration Statement or Prospectus in connection with such sale, if
         any, before filing with the Commission, copies of any Registration
         Statement or any Prospectus included therein or any amendments or
         supplements to any such Registration Statement or Prospectus (including
         all documents incorporated by reference after the initial filing of
         such Registration Statement), which documents will be subject to the
         review and comment of such Holders in connection with such sale, if
         any, for a period of at least five Business Days, and the Company will
         not file any such Registration Statement or Prospectus or any amendment
         or supplement to any such Registration Statement or Prospectus
         (including all such documents incorporated by reference) to which the
         selling Holders of the Transfer Restricted Securities covered by such
         Registration Statement in connection with such sale, if any, shall
         reasonably object within five Business Days after the receipt thereof.
         A selling Holder shall be deemed to have reasonably objected to such
         filing if such Registration Statement, amendment, Prospectus or
         supplement, as applicable, as proposed to be filed, contains an untrue
         statement of a material fact or omits to state any material fact
         necessary to make the statements therein not misleading or fails to
         comply with the applicable requirements of the Act;

                  (vi)     with respect to a Shelf Registration Statement, the
         Company will use reasonable efforts promptly prior to the filing of any
         document that is to be incorporated by reference into a Registration
         Statement or Prospectus, to provide copies of such document to the
         selling Holders in connection with such sale, if any, make the
         Company's and the Guarantors' representatives available for discussion
         of such document and other customary due diligence matters, and include
         such information in such document prior to the filing thereof as such
         selling Holders may reasonably request;

                  (vii)    with respect to a Shelf Registration Statement, make
         available at reasonable times for inspection by the selling Holders
         participating in any disposition pursuant to such Registration
         Statement and any attorney or accountant retained by such selling
         Holders, all financial and other records, pertinent corporate documents
         of the Company and the Guarantors and cause the Company's and the
         Guarantors' officers, directors and employees to supply all information
         reasonably requested by any such selling Holder, attorney or accountant
         in connection with such Registration Statement or any post-effective
         amendment thereto subsequent to the filing thereof and prior to its
         effectiveness;

                  (viii)   with respect to a Shelf Registration Statement, if
         requested by any selling Holders in connection with such sale, if any,
         promptly include in any Registration Statement or Prospectus, pursuant
         to a supplement or post-effective amendment if necessary, such
         information as such selling Holders may reasonably request to have
         included therein, including, without limitation, information relating
         to the "Plan of Distribution" of the Transfer Restricted Securities;
         and make all required filings of such Prospectus supplement or
         post-effective amendment as soon as practicable after the Company is
         notified of the matters to be included in such Prospectus supplement or
         post-effective amendment;

                                       10

<PAGE>

                  (ix)     with respect to a Shelf Registration Statement,
         furnish to each selling Holder in connection with such sale, if any,
         without charge, one copy of the Registration Statement, as first filed
         with the Commission, and of each amendment thereto, including all
         documents incorporated by reference therein and all exhibits (including
         exhibits incorporated therein by reference);

                  (x)      with respect to a Shelf Registration Statement,
         deliver to each selling Holder, without charge, as many copies of the
         Prospectus (including each preliminary prospectus) and any amendment or
         supplement thereto as such Persons reasonably may request; the Company
         and the Guarantors hereby consent to the use (in accordance with law)
         of the Prospectus and any amendment or supplement thereto by each of
         the selling Holders in connection with the offering and the sale of the
         Transfer Restricted Securities covered by the Prospectus or any
         amendment or supplement thereto;

                  (xi)     with respect to a Shelf Registration Statement, upon
         the request of any selling Holder, enter into such agreements
         (including underwriting agreements containing customary terms) and make
         such representations and warranties and take all such other actions in
         connection therewith in order to expedite or facilitate the disposition
         of the Transfer Restricted Securities pursuant to any applicable
         Registration Statement contemplated by this Agreement as may be
         reasonably requested by any Holder of Transfer Restricted Securities in
         connection with any sale or resale pursuant to any applicable
         Registration Statement. In such connection, the Company and the
         Guarantors shall:

                  (A)      upon request of any selling Holder, furnish (or in
            the case of paragraphs (2) and (3), use its commercially reasonable
            efforts to cause to be furnished) to each selling Holder, upon the
            effectiveness of the Shelf Registration Statement:

                           (1)      a certificate, dated such date, signed on
                  behalf of the Company and each Guarantor by (x) the President
                  or any Vice President and (y) a principal financial or
                  accounting officer of the Company and such Guarantor,
                  confirming, as of the date thereof, the matters, to the extent
                  applicable, set forth in paragraphs (a) and (b) of Section 6
                  of the Purchase Agreement and such other similar matters as
                  the selling Holders may reasonably request;

                           (2)      an opinion, dated the date of effectiveness
                  of the Shelf Registration Statement of counsel for the Company
                  and the Guarantors covering matters similar to those set forth
                  in Section 6(e) of the Purchase Agreement (as to the
                  Registration Statement rather than the Offering Memorandum and
                  excepting the clauses (vi), (vii), (viii), (x), (xii), (xiii),
                  and (xviii) of Section 6(e) of the Purchase Agreement) and
                  such other matters as the selling Holders may reasonably
                  request, and in any event including a statement to the effect
                  that such counsel has participated in conferences with
                  officers and other representatives of the Company and the
                  Guarantors, representatives of the independent public
                  accountants for the Company and the Guarantors and have
                  considered the matters required to be stated therein and the
                  statements contained therein, although such counsel has not
                  independently verified the accuracy, completeness or fairness
                  of such statements; and that such counsel advises that, on the
                  basis of the foregoing (relying as to materiality to the
                  extent such counsel deems appropriate upon the statements of
                  officers and other

                                       11

<PAGE>

                  representatives of the Company and the Guarantors and without
                  independent check or verification), no facts came to such
                  counsel's attention that caused such counsel to believe that
                  the applicable Registration Statement, at the time such
                  Registration Statement or any post-effective amendment thereto
                  became effective, contained an untrue statement of a material
                  fact or omitted to state a material fact required to be stated
                  therein or necessary to make the statements therein not
                  misleading, or that the Prospectus contained in such
                  Registration Statement as of its date, contained an untrue
                  statement of a material fact or omitted to state a material
                  fact necessary in order to make the statements therein, in the
                  light of the circumstances under which they were made, not
                  misleading. Without limiting the foregoing, such counsel may
                  state further that such counsel assumes no responsibility for,
                  and has not independently verified, the accuracy, completeness
                  or fairness of the financial statements, notes and schedules
                  and other financial data included in any Registration
                  Statement contemplated by this Agreement or the related
                  Prospectus; and

                           (3)      a customary comfort letter, dated the date
                  of effectiveness of the Shelf Registration Statement from the
                  Company's independent accountants, in the customary form and
                  covering matters of the type customarily covered in comfort
                  letters to underwriters in connection with underwritten
                  offerings, and affirming the matters set forth in the comfort
                  letters delivered pursuant to Section 6(f) of the Purchase
                  Agreement;

                  (B)      set forth in full or incorporated by reference in the
            underwriting agreement, if any, the indemnification provisions and
            procedures of Section 8 hereof with respect to all parties to be
            indemnified pursuant to said Section; and

                  (C)      deliver such other documents and certificates as may
            be reasonably requested by the selling Holders to evidence
            compliance with clause (A) above and with any customary conditions
            contained in any agreement entered into by the Company and the
            Guarantors pursuant to this clause (xi);

                  If at any time the representations and warranties of the
         Company and each of the Guarantors set forth in the certificate
         contemplated in clause (A)(1) above cease to be true and correct, the
         Company shall so advise the Initial Purchasers and the underwriters, if
         any, and each selling Holder promptly and, if requested by such
         Persons, shall confirm such advice in writing;

                  (xii)    prior to any public offering of Transfer Restricted
         Securities, cooperate with the selling Holders and their counsel in
         connection with the registration and qualification of the Transfer
         Restricted Securities under the securities or Blue Sky laws of such
         jurisdictions as the selling Holders may request and do any and all
         other acts or things necessary or advisable to enable the disposition
         in such jurisdictions of the Transfer Restricted Securities covered by
         the applicable Registration Statement; provided, however, that neither
         the Company nor any Guarantor shall be required to register or qualify
         as a foreign corporation where it is not now so qualified or to take
         any action that would subject it to the service of process in suits or
         to taxation, other than as to matters and transactions relating to the
         Registration Statement, in any jurisdiction where it is not now so
         subject;

                                       12

<PAGE>

                  (xiii)   issue, upon the request of any Holder of Series A
         Notes covered by any Shelf Registration Statement contemplated by this
         Agreement, Series B Notes having an aggregate principal amount equal to
         the aggregate principal amount of Series A Notes surrendered to the
         Company by such Holder in exchange therefor or being sold by such
         Holder, such Series B Notes to be registered in the name of such Holder
         or in the name of the purchaser(s) of such Series B Notes; in return,
         the Series A Notes held by such Holder shall be surrendered to the
         Company for cancellation;

                  (xiv)    in connection with any sale of Transfer Restricted
         Securities that will result in such securities no longer being Transfer
         Restricted Securities, cooperate with the Holders to facilitate the
         timely preparation and delivery of certificates representing Transfer
         Restricted Securities to be sold and not bearing any restrictive
         legends; and to register such Transfer Restricted Securities in such
         denominations and such names as the selling Holders may request at
         least two Business Days prior to such sale of Transfer Restricted
         Securities;

                  (xv)     provide a CUSIP number for all Transfer Restricted
         Securities not later than the effective date of a Registration
         Statement covering such Transfer Restricted Securities and provide the
         Trustee under the Indenture with printed certificates for the Transfer
         Restricted Securities which are in a form eligible for deposit with The
         Depository Trust Company;

                  (xvi)    otherwise use their commercially reasonable efforts
         to comply with all applicable rules and regulations of the Commission,
         and make generally available to its security holders with regard to any
         applicable Registration Statement, as soon as practicable, a
         consolidated earnings statement meeting the requirements of Rule 158
         (which need not be audited) covering a twelve-month period beginning
         after the effective date of the Registration Statement (as such term is
         defined in paragraph (c) of Rule 158 under the Act);

                  (xvii)   cause the Indenture to be qualified under the TIA not
         later than the effective date of the first Registration Statement
         required by this Agreement and, in connection therewith, cooperate with
         the Trustee and the Holders to effect such changes to the Indenture as
         may be required for such Indenture to be so qualified in accordance
         with the terms of the TIA; and execute and use their commercially
         reasonable efforts to cause the Trustee to execute, all documents that
         may be required to effect such changes and all other forms and
         documents required to be filed with the Commission to enable such
         Indenture to be so qualified in a timely manner; and

                  (xviii)  provide promptly to each Holder, upon request, each
         document filed with the Commission pursuant to the requirements of
         Section 13 or Section 15(d) of the Exchange Act.

         (d)      Restrictions on Holders. Each Holder agrees by acquisition of
a Transfer Restricted Security that, upon receipt of the notice referred to in
Section 6(c)(iii)(C) or any notice from the Company of the existence of any fact
of the kind described in Section 6(c)(i) or Section 6(c)(iii)(D) hereof (in each
case, a "Suspension Notice"), such Holder will forthwith discontinue disposition
of Transfer Restricted Securities pursuant to the applicable Registration
Statement until (i) such Holder has received copies of the supplemented or
amended Prospectus contemplated by Section 6(c)(iv) hereof, or (ii) such Holder
is advised in writing by the Company that the use of the

                                       13

<PAGE>

Prospectus may be resumed, and has received copies of any additional or
supplemental filings that are incorporated by reference in the Prospectus (in
each case, the "Recommencement Date"). Each Holder receiving a Suspension Notice
hereby agrees that it will either (i) destroy any Prospectuses, other than
permanent file copies, then in such Holder's possession which have been replaced
by the Company with more recently dated Prospectuses or (ii) deliver to the
Company (at the Company's expense) all copies, other than permanent file copies,
then in such Holder's possession of the Prospectus covering such Transfer
Restricted Securities that was current at the time of receipt of the Suspension
Notice. The time period regarding the effectiveness of such Registration
Statement set forth in Section 3 or 4 hereof, as applicable, shall be extended
by a number of days equal to the number of days in the period from and including
the date of delivery of the Suspension Notice to the Recommencement Date.

SECTION 7. REGISTRATION EXPENSES

         (a)      All expenses incident to the Company's and the Guarantors'
performance of or compliance with this Agreement will be borne by the Company
and the Guarantors, regardless of whether a Registration Statement becomes
effective, including without limitation: (i) all registration and filing fees
and expenses; (ii) all fees and expenses of compliance with federal securities
and state Blue Sky or securities laws; (iii) all expenses of printing (including
printing certificates for the Series B Notes to be issued in the Exchange Offer
and printing of Prospectuses), messenger and delivery services and telephone;
(iv) all fees and disbursements of counsel for the Company and the Guarantors;
(v) all application and filing fees in connection with listing the Series B
Notes on a national securities exchange or automated quotation system pursuant
to the requirements hereof; and (vi) all fees and disbursements of independent
certified public accountants of the Company and the Guarantors (including the
expenses of any special audit and comfort letters required by or incident to
such performance).

         The Company will, in any event, bear its and the Guarantors' internal
expenses (including, without limitation, all salaries and expenses of its
officers and employees performing legal or accounting duties), the expenses of
any annual audit and the fees and expenses of any Person, including special
experts, retained by the Company or the Guarantors.

         (b)      In connection with any Registration Statement required by this
Agreement (including, without limitation, the Exchange Offer Registration
Statement and the Shelf Registration Statement), the Company and the Guarantors
will reimburse the Initial Purchasers and the Holders of Transfer Restricted
Securities being tendered in the Exchange Offer and/or resold pursuant to the
"Plan of Distribution" contained in the Exchange Offer Registration Statement or
registered pursuant to the Shelf Registration Statement, as applicable, for the
reasonable fees and disbursements of not more than one counsel (not to exceed
$25,000), who shall be Latham & Watkins LLP, unless another firm shall be chosen
by the Holders of a majority in principal amount of the Transfer Restricted
Securities for whose benefit such Registration Statement is being prepared.

SECTION 8. INDEMNIFICATION

         (a)      The Company and the Guarantors, jointly and severally, agree
to indemnify and hold harmless (i) each Holder and (ii) each Person, if any, who
controls (within the meaning of Section 15 of the Act or Section 20 of the
Exchange Act) any Holder (any of the persons referred to in this clause (ii)
being hereinafter referred to as a "controlling person") and (iii) the
respective

                                       14

<PAGE>

officers, directors, partners and employees of any Holder or any controlling
person (any person referred to in clause (i), (ii) or (iii) may hereinafter be
referred to as an "Indemnified Holder"), from and against any and all losses,
claims, damages, liabilities, judgments, (including without limitation, any
legal or other expenses reasonably incurred in connection with investigating or
defending any matter, including any action that could give rise to any such
losses, claims, damages, liabilities or judgments) caused by any untrue
statement or alleged untrue statement of a material fact contained in any
Registration Statement, preliminary prospectus or Prospectus (or any amendment
or supplement thereto) provided by the Company to any Holder or any prospective
purchaser of Series B Notes or registered Series A Notes, or caused by any
omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein not misleading,
except insofar as such losses, claims, damages, liabilities or judgments are
caused by an untrue statement or omission or alleged untrue statement or
omission that is based upon information relating to any of the Holders furnished
in writing to the Company by any of the Holders.

         (b)      Each Holder of Transfer Restricted Securities agrees,
severally and not jointly, to indemnify and hold harmless the Company and the
Guarantors, and their respective directors and officers, and each person, if
any, who controls (within the meaning of Section 15 of the Act or Section 20 of
the Exchange Act) the Company or the Guarantors to the same extent as the
foregoing indemnity from the Company and the Guarantors to each of the
Indemnified Holders, but only with reference to information relating to such
Indemnified Holder furnished in writing to the Company by such Indemnified
Holder expressly for use in any Registration Statement. In no event shall any
Indemnified Holder be liable or responsible for any amount in excess of the
amount by which the total amount received by such Indemnified Holder with
respect to its sale of Transfer Restricted Securities pursuant to a Registration
Statement exceeds the amount paid by such Indemnified Holder for such Transfer
Restricted Securities.

         (c)      In case any action shall be commenced involving any person in
respect of which indemnity may be sought pursuant to Section 8(a) or 8(b) hereof
(the "indemnified party"), the indemnified party shall promptly notify the
person against whom such indemnity may be sought (the "indemnifying person") in
writing and the indemnifying party shall assume the defense of such action,
including the employment of counsel reasonably satisfactory to the indemnified
party and the payment of all fees and expenses of such counsel, as incurred
(except that in the case of any action in respect of which indemnity may be
sought pursuant to both Sections 8(a) and 8(b), an Indemnified Holder shall not
be required to assume the defense of such action pursuant to this Section 8(c),
but may employ separate counsel and participate in the defense thereof, but the
fees and expenses of such counsel, except as provided below, shall be at the
expense of the Indemnified Holder). Any indemnified party shall have the right
to employ separate counsel in any such action and participate in the defense
thereof, but the fees and expenses of such counsel shall be at the expense of
the indemnified party unless (i) the employment of such counsel shall have been
specifically authorized in writing by the indemnifying party, (ii) the
indemnifying party shall have failed to assume the defense of such action or
employ counsel reasonably satisfactory to the indemnified party or (iii) the
named parties to any such action (including any impleaded parties) include both
the indemnified party and the indemnifying party, and the indemnified party
shall have been advised by such counsel that there may be one or more legal
defenses available to it which are different from or additional to those
available to the indemnifying party (in which case the indemnifying party shall
not have the right to assume the defense of such action on behalf of the
indemnified party). In any such case, the indemnifying party shall not, in
connection with any

                                       15

<PAGE>

one action or separate but substantially similar or related actions in the same
jurisdiction arising out of the same general allegations or circumstances, be
liable for the fees and expenses of more than one separate firm of attorneys (in
addition to any local counsel) for all indemnified parties and all such fees and
expenses shall be reimbursed as they are incurred. Such firm shall be designated
in writing by a majority of the Indemnified Holders, in the case of the parties
indemnified pursuant to Section 8(a), and by the Company, in the case of parties
indemnified pursuant to Section 8(b). The indemnifying party shall indemnify and
hold harmless the indemnified party from and against any and all losses, claims,
damages, liabilities and judgments by reason of any settlement of any action
effected with its written consent. No indemnifying party shall, without the
prior written consent of the indemnified party, effect any settlement or
compromise of, or consent to the entry of judgment with respect to, any pending
or threatened action in respect of which the indemnified party is or could have
been a party and indemnity or contribution may be or could have been sought
hereunder by the indemnified party, unless such settlement, compromise or
judgment (i) includes an unconditional release of the indemnified party from all
liability on claims that are or could have been the subject matter of such
action and (ii) does not include a statement as to or an admission of fault,
culpability or a failure to act, by or on behalf of the indemnified party.

         (d)      To the extent that the indemnification provided for in this
Section 8 is unavailable to an indemnified party in respect of any losses,
claims, damages, liabilities or judgments referred to therein, then each
indemnifying party, in lieu of indemnifying such indemnified party, shall
contribute to the amount paid or payable by such indemnified party as a result
of such losses, claims, damages, liabilities or judgments (i) in such proportion
as is appropriate to reflect the relative benefits received by the Company and
the Guarantors, on the one hand, and the Holders, on the other hand, from their
sale of Transfer Restricted Securities or (ii) if the allocation provided by
clause 8(d)(i) is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause
8(d)(i) above but also the relative fault of the Company and the Guarantors, on
the one hand, and of the Indemnified Holder, on the other hand, in connection
with the statements or omissions which resulted in such losses, claims, damages,
liabilities or judgments, as well as any other relevant equitable
considerations. The relative fault of the Company and the Guarantors, on the one
hand, and of the Indemnified Holder, on the other hand, shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement
of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company or such Guarantor, on the one
hand, or by the Indemnified Holder, on the other hand, and the parties' relative
intent, knowledge, access to information and opportunity to correct or prevent
such statement or omission. The amount paid or payable by a party as a result of
the losses, claims, damages, liabilities and judgments referred to above shall
be deemed to include any legal or other fees or expenses reasonably incurred by
such party in connection with investigating or defending any action or claim.

         The Company, the Guarantors and each Holder agree that it would not be
just and equitable if contribution pursuant to this Section 8(d) were determined
by pro rata allocation (even if the Holders were treated as one entity for such
purpose) or by any other method of allocation which does not take account of the
equitable considerations referred to in the immediately preceding paragraph. The
amount paid or payable by an indemnified party as a result of the losses,
claims, damages, liabilities or judgments referred to in the immediately
preceding paragraph shall be deemed to include, subject to the limitations set
forth above, any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any matter, including any
action that could have given rise to such losses, claims, damages, liabilities

                                       16

<PAGE>

or judgments. Notwithstanding the provisions of this Section 8, no Holder or its
related Indemnified Holders shall be required to contribute, in the aggregate,
any amount in excess of the amount by which the total received by such Holder
with respect to the sale of Transfer Restricted Securities pursuant to a
Registration Statement exceeds the sum of (A) the amount paid by such Holder for
such Transfer Restricted Securities plus (B) the amount of any damages which
such Holder has otherwise been required to pay by reason of such untrue or
alleged untrue statement or omission or alleged omission. No person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the Act)
shall be entitled to contribution from any person who was not guilty of such
fraudulent misrepresentation. The Holders' obligations to contribute pursuant to
this Section 8(c) are several in proportion to the respective principal amount
of Transfer Restricted Securities held by each Holder hereunder and not joint.

         The agreements contained in this Section 8 shall survive the sale of
the Transfer Restricted Securities pursuant to a Registration Statement and
shall remain in full force and effect regardless of any termination or
cancellation of this Agreement.

SECTION 9. RULE 144A AND RULE 144

         The Company and each Guarantor hereby agrees with each Holder, for so
long as any Transfer Restricted Securities remain outstanding and during any
period in which the Company or such Guarantor is not subject to Section 13 or
15(d) of the Exchange Act, to make available, upon request of any Holder of
Transfer Restricted Securities, to any Holder or beneficial owner of Transfer
Restricted Securities in connection with any sale thereof and any prospective
purchaser of such Transfer Restricted Securities designated by such Holder or
beneficial owner, the information required by Rule 144A(d)(4) under the Act in
order to permit resales of such Transfer Restricted Securities pursuant to Rule
144A.

SECTION 10. MISCELLANEOUS

         (a)      Remedies. The Company and the Guarantors acknowledge and agree
that any failure by the Company and/or the Guarantors to comply with their
respective obligations under Sections 3 and 4 hereof may result in material
irreparable injury to the Initial Purchasers or the Holders for which there is
no adequate remedy at law, that it will not be possible to measure damages for
such injuries precisely and that, in the event of any such failure, the Initial
Purchasers or any Holder may obtain such relief as may be required to
specifically enforce the Company's and the Guarantors' obligations under
Sections 3 and 4 hereof. The Company and the Guarantors further agree to waive
the defense in any action for specific performance that a remedy at law would be
adequate.

         (b)      No Inconsistent Agreements. Neither the Company nor any
Guarantor will, on or after the date of this Agreement, enter into any agreement
with respect to its securities that is inconsistent with the rights granted to
the Holders in this Agreement or otherwise conflicts with the provisions hereof.
Neither the Company nor any Guarantor has previously entered into any agreement
granting any registration rights with respect to its securities to any Person.
The rights granted to the Holders hereunder do not in any way conflict with and
are not inconsistent with the rights granted to the holders of the Company's and
the Guarantors' securities under any agreement in effect on the date hereof.

                                       17

<PAGE>

         (c)      Adjustments Affecting the Notes. Neither the Company nor any
of the Guarantors shall take any action, or permit any change to occur, with
respect to the Notes that would materially and adversely affect the ability of
the Holders to Consummate any Exchange Offer.

         (d)      Amendments and Waivers. The provisions of this Agreement may
not be amended, modified or supplemented, and waivers or consents to or
departures from the provisions hereof may not be given unless (i) in the case of
Section 5 hereof and this Section 10(d)(i), the Company has obtained the written
consent of Holders of all outstanding Transfer Restricted Securities and (ii) in
the case of all other provisions hereof, the Company has obtained the written
consent of Holders of a majority of the outstanding principal amount of Transfer
Restricted Securities (excluding Transfer Restricted Securities held by the
Company or its Affiliates). Notwithstanding the foregoing, a waiver or consent
to departure from the provisions hereof that relates exclusively to the rights
of Holders whose securities are being tendered pursuant to the Exchange Offer,
and that does not affect directly or indirectly the rights of other Holders
whose securities are not being tendered pursuant to such Exchange Offer, may be
given by the Holders of a majority of the outstanding principal amount of
Transfer Restricted Securities subject to such Exchange Offer.

         (e)      Third Party Beneficiary. The Holders shall be third party
beneficiaries to the agreements made hereunder between the Company and the
Guarantors, on the one hand, and the Initial Purchasers, on the other hand, and
shall have the right to enforce such agreements directly to the extent they may
deem such enforcement necessary or advisable to protect its rights or the rights
of Holders hereunder.

         (f)      Notices. All notices and other communications provided for or
permitted hereunder shall be made in writing by hand-delivery, first-class mail
(registered or certified, return receipt requested), telex, telecopier, or air
courier guaranteeing overnight delivery:

                  (i)      if to a Holder, at the address set forth on the
         records of the Registrar under the Indenture, with a copy to the
         Registrar under the Indenture; and

                  (ii)     if to the Company or the Guarantors:

                           IASIS Healthcare Corporation
                           113 Seaboard Lane
                           Suite A-200
                           Franklin, TN 37067
                           Facsimile No.: (615) 846-3006
                           Attention: General Counsel
                           With a copy to:

                           Skadden, Arps, Slate, Meagher & Flom LLP
                           One Rodney Square, 7th Floor
                           Wilmington, DE 19801
                           Facsimile No.: (302) 651-3001
                           Attention: Robert B. Pincus

         All such notices and communications shall be deemed to have been duly
given: at the time delivered by hand, if personally delivered; five Business
Days after being deposited in the mail,

                                       18

<PAGE>

postage prepaid, if mailed; when receipt acknowledged, if sent by facsimile; and
on the next business day, if timely delivered to an air courier guaranteeing
overnight delivery.

         Copies of all such notices, demands or other communications shall be
concurrently delivered by the Person giving the same to the Trustee at the
address specified in the Indenture.

         Upon the date of filing of the Exchange Offer or a Shelf Registration
Statement, as the case may be, notice shall be delivered to the Initial
Purchasers in the form attached hereto as Exhibit A.

         (g)      Successors and Assigns. This Agreement shall inure to the
benefit of and be binding upon the successors and assigns of each of the
parties, including without limitation and without the need for an express
assignment, subsequent Holders of Transfer Restricted Securities; provided, that
nothing herein shall be deemed to permit any assignment, transfer or other
disposition of Transfer Restricted Securities in violation of the terms hereof
or of the Purchase Agreement or the Indenture. If any transferee of any Holder
shall acquire Transfer Restricted Securities in any manner, whether by operation
of law or otherwise, such Transfer Restricted Securities shall be held subject
to all of the terms of this Agreement, and by taking and holding such Transfer
Restricted Securities such Person shall be conclusively deemed to have agreed to
be bound by and to perform all of the terms and provisions of this Agreement,
including the restrictions on resale set forth in this Agreement and, if
applicable, the Purchase Agreement, and such Person shall be entitled to receive
the benefits hereof.

         (h)      Counterparts. This Agreement may be executed in any number of
counterparts and by the parties hereto in separate counterparts, each of which
when so executed shall be deemed to be an original and all of which taken
together shall constitute one and the same agreement.

         (i)      Headings. The headings in this Agreement are for convenience
of reference only and shall not limit or otherwise affect the meaning hereof.

         (j)      Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD
TO THE CONFLICT OF LAWS PROVISIONS THEREOF. EACH OF THE PARTIES HERETO AGREES TO
SUBMIT TO THE JURISDICTION OF THE COURTS OF THE STATE OF NEW YORK IN ANY ACTION
OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT.

         (k)      Severability. In the event that any one or more of the
provisions contained herein, or the application thereof in any circumstance, is
held invalid, illegal or unenforceable, the validity, legality and
enforceability of any such provision in every other respect and of the remaining
provisions contained herein shall not be affected or impaired thereby.

         (l)      Entire Agreement. This Agreement is intended by the parties as
a final expression of their agreement and intended to be a complete and
exclusive statement of the agreement and understanding of the parties hereto in
respect of the subject matter contained herein. There are no restrictions,
promises, warranties or undertakings, other than those set forth or referred to
herein with respect to the registration rights granted with respect to the
Transfer Restricted Securities. This Agreement supersedes all prior agreements
and understandings between the parties with respect to such subject matter.

                            [Signature page follows]

                                       19

<PAGE>

         IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date first written above.

                                         IASIS HEALTHCARE CORPORATION

                                         By:  /s/ David R. White
                                            --------------------------
                                              Name:  David R. White
                                              Title: President and Chief
                                                     Executive Officer

<PAGE>

                          Accepted as of the date written above:

                          ARIZONA DIAGNOSTIC & SURGICAL CENTER, INC.
                          BAPTIST JOINT VENTURE HOLDINGS, INC.
                          BEAUMONT HOSPITAL HOLDINGS, INC.
                          BILTMORE SURGERY CENTER HOLDINGS, INC.
                          CLINICARE OF UTAH, INC.
                          DAVIS HOSPITAL & MEDICAL CENTER, INC.
                          DAVIS SURGICAL CENTER HOLDINGS, INC.
                          FIRST CHOICE PHYSICIANS NETWORK HOLDINGS, INC.
                          IASIS HEALTHCARE HOLDINGS, INC.
                          IASIS MANAGEMENT COMPANY
                          JORDAN VALLEY HOSPITAL HOLDINGS, INC.
                          METRO AMBULATORY SURGERY CENTER, INC.
                          PIONEER VALLEY HEALTH PLAN, INC.
                          PIONEER VALLEY HOSPITAL, INC.
                          ROCKY MOUNTAIN MEDICAL CENTER, INC.
                          SALT LAKE REGIONAL MEDICAL CENTER, INC.
                          SANDY CITY HOLDINGS, INC.
                          SOUTHRIDGE PLAZA HOLDINGS, INC.
                          SSJ ST. PETERSBURG HOLDINGS, INC.
                          BROOKWOOD DIAGNOSTIC CENTER OF TAMPA, INC.
                          IASIS PHYSICIANS SERVICES, INC.
                          CLINICARE OF TEXAS, INC.
                          IASIS FINANCE, INC.
                          IASIS HOME INFUSION AND MEDICAL EQUIPMENT, INC.
                          IASIS TRANSCO, INC.
                          MCS/AZ, INC.
                          PALMS OF PASADENA HOMECARE, INC.
                          TAMPA BAY STAFFING SOLUTIONS, INC.
                          IASIS HEALTHCARE MSO SUB OF SALT LAKE CITY, LLC
                          BILTMORE SURGERY CENTER, INC.

                      By: /s/ W. Carl Whitmer
                         -------------------------------
                          Name:  W. Carl Whitmer
                          Title: Chief Financial Officer

<PAGE>

                          Accepted as of the date written above:

                          GUARANTORS (CONTINUED):

                          MEMORIAL HOSPITAL OF TAMPA, LP
                          MESA GENERAL HOSPITAL, LP
                          ODESSA REGIONAL HOSPITAL, LP
                          PALMS OF PASADENA HOSPITAL, LP
                          SOUTHWEST GENERAL HOSPITAL, LP
                          ST. LUKE'S BEHAVIORAL HOSPITAL, LP
                          ST. LUKE'S MEDICAL CENTER, LP
                          TEMPE ST. LUKE'S HOSPITAL, LP
                          TOWN & COUNTRY HOSPITAL, LP
                          JORDAN VALLEY HOSPITAL, LP
                          SOUTHEAST TEXAS HOSPITAL, LP

                      By: IASIS HEALTHCARE HOLDINGS, INC.

                          By: /s/ W. Carl Whitmer
                              --------------------------------------
                              Name:  W. Carl Whitmer
                              Title: Chief Financial Officer

<PAGE>

Accepted as of the date written above:

BANC OF AMERICA SECURITIES, LLC

By: /s/ Lex Maultsby
    -------------------------------
    Name:  Lex Maultsby
    Title: Principal

<PAGE>

Accepted as of the date written above:

BEAR, STEARNS & CO. INC.

By: /s/ Lawrence B. Alletto
    -------------------------------
    Name:  Lawrence B. Alletto
    Title: Senior Managing Director

<PAGE>

Accepted as of the date written above:

CITIGROUP GLOBAL MARKETS INC.

By: /s/ Richard C. Zogheb
    -------------------------------
    Name:  Richard C. Zogheb
    Title: Managing Director

<PAGE>

                                    EXHIBIT A

                               NOTICE OF FILING OF
                      EXCHANGE OFFER REGISTRATION STATEMENT

To:    Banc of America Securities, LLC
       Bear, Stearns & Co. Inc.
       Citigroup Global Markets Inc.
                c/o Banc of America Securities, LLC
                9 West 57th Street, 2M Floor
                New York, NY 10019
                Attn: High Yield Syndicate Department
                Fax: (212) 583-8324

From:  IASIS Healthcare Corporation
       113 Seaboard Lane
       Suite A-200
       Franklin, TN 37067
       Fax: (615) 846-3006

Re: 8 1/2% Senior Subordinated Notes Due 2009

Date: ________________, 2003

         For your information only (NO ACTION REQUIRED):

                  Today, ________________, 2003, we filed [an Exchange
Registration Statement] [a Shelf Registration Statement] with the Securities and
Exchange Commission. We currently expect this registration statement to be
declared effective within __ business days of the date hereof.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00053-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00053-of-00352.parquet"}]]